-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-05-22
3020-OL:HK:HK-X DBMSCIUSA (HKD)
COMMON STOCK | Other |
Last Closing
USD 1217.5Change
+1.00 (+0.08)%Market Cap
N/AVolume
15.00Analyst Target
N/A![](https://ducovest.com/tools/assets/assets/images/analyst-meter.png)
N/A
Verdict
Values as of: 2024-05-22
COMMON STOCK | Other |
Last Closing
USD 1217.5Change
+1.00 (+0.08)%Market Cap
N/AVolume
15.00Analyst Target
N/AN/A
Verdict
Currency: HKD
Country : Hong Kong
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
1863:HK | China Longevity Group Company .. |
N/A |
USD 1.17B |
8355:HK | I-CONTROL |
N/A |
USD 0.39B |
8343:HK | HongGuang Lighting Holdings Co.. |
N/A |
USD 0.31B |
0648:HK | CHINA RENJ |
N/A |
USD 0.12B |
0177-OL:HK | JIANGSU EXPRESS |
N/A |
N/A |
0240-OL:HK | BUILD KING HOLD |
N/A |
N/A |
0243-OL:HK | QPL INT'L |
N/A |
N/A |
0182-OL:HK | CHINA WINDPOWER |
N/A |
N/A |
0259-OL:HK | YEEBO (INT'L H) |
N/A |
N/A |
0187-OL:HK | JINGCHENG MAC |
N/A |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
TETF | 6.19 % | 0.64 % |
N/A |
N/A | |
FHI-B:CA | CI Health Care Giants Cov.. | 5.32 % | 0.00 % |
N/A |
CAD 0.05B |
LCG | Sterling Capital Focus Eq.. | 4.48 % | 0.00 % |
N/A |
USD 0.06B |
MID | American Century Mid Cap .. | 4.14 % | 0.00 % |
N/A |
USD 0.07B |
STNC | Stance Equity ESG Large C.. | 3.75 % | 0.00 % |
N/A |
USD 0.11B |
CBUF:XETRA | iShares MSCI World Health.. | 3.29 % | 0.00 % |
N/A |
USD 1.13B |
HDIV | 2.83 % | 0.00 % |
N/A |
N/A | |
SPVU | Invesco S&P 500® Enhance.. | 2.64 % | 0.16 % |
N/A |
USD 0.12B |
FHH:CA | First Trust AlphaDEX US H.. | 2.06 % | 0.77 % |
N/A |
CAD 9.66M |
FHH-F:CA | First Trust AlphaDEX U.S... | 2.06 % | 0.00 % |
N/A |
CAD 0.01B |
FDWM | Fidelity Covington Trust .. | 1.91 % | 0.00 % |
N/A |
USD 4.40M |
RYH | 1.72 % | 0.40 % |
N/A |
N/A | |
SPVM | Invesco S&P 500 Value wit.. | 1.72 % | 0.39 % |
N/A |
USD 0.09B |
ZUH:CA | BMO Equal Weight US Healt.. | 1.62 % | 0.39 % |
N/A |
CAD 0.29B |
IQSA:XETRA | Invesco Quantitative Stra.. | 1.53 % | 0.00 % |
N/A |
USD 0.07B |
IQSE:XETRA | Invesco Quantitative Stra.. | 1.53 % | 0.00 % |
N/A |
USD 0.05B |
IS07:F | iShares IV Public Limited.. | 1.50 % | 0.00 % |
N/A |
N/A |
IS07:XETRA | iShares Edge MSCI World M.. | 1.50 % | 0.00 % |
N/A |
USD 0.01B |
IFSW:LSE | iShares Edge MSCI World M.. | 1.47 % | 0.00 % |
N/A |
USD 0.53B |
FSWD:LSE | iShares Edge MSCI World M.. | 1.46 % | 0.00 % |
N/A |
N/A |
IBCZ:F | iShares IV Public Limited.. | 1.46 % | 0.00 % |
N/A |
USD 0.46B |
IBCZ:XETRA | iShares Edge MSCI World M.. | 1.46 % | 0.00 % |
N/A |
USD 0.40B |
HONR | 1.20 % | 0.65 % |
N/A |
N/A | |
VVL:CA | Vanguard Global Value Fac.. | 0.72 % | 0.40 % |
N/A |
CAD 0.36B |
SMD | 0.45 % | 0.10 % |
N/A |
N/A | |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
N/A |
USD 0.02B |
DRFU:CA | Desjardins RI USA Multifa.. | 0.00 % | 0.57 % |
N/A |
CAD 5.97M |
RYF | 0.00 % | 0.40 % |
N/A |
N/A | |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
XMWD:LSE | Xtrackers MSCI World Swap.. | 0.00 % | 0.00 % |
N/A |
USD 4.24B |
IMCG | iShares Morningstar Mid-C.. | 0.00 % | 0.00 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 12.84% | 65% | D | 70% | C- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 12.84% | 64% | D | 69% | C- | ||
Trailing 12 Months | |||||||
Capital Gain | 30.02% | 85% | B | 85% | B | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 30.02% | 82% | B | 83% | B | ||
Trailing 5 Years | |||||||
Capital Gain | 101.41% | 83% | B | 90% | A- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 101.41% | 83% | B | 89% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 15.10% | 80% | B- | 79% | B- | ||
Dividend Return | 15.10% | 78% | C+ | 77% | C+ | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 19.50% | 75% | C | 73% | C | ||
Risk Adjusted Return | 77.44% | 98% | N/A | 98% | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
There is nothing we particularly dislike